Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

THE EFFECT OF GENISTEIN IN ORAL SQUAMOUS CELL CARCINOMA WITH RESPECT TO THE ANGIOGENESIS AND BASEMENT MEMBRANE INVASION

구강편평세포암종에서 신생혈관화와 기저막침습에 미치는 제니스타인의 효과

  • Kim, Yong-Hun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) ;
  • Yun, Pil-Young (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) ;
  • Myoung, Hoon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) ;
  • Kim, Myung-Jin (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University)
  • 김용훈 (서울대학교 치과대학 구강악안면외과학교실) ;
  • 윤필영 (서울대학교 치과대학 구강악안면외과학교실) ;
  • 명훈 (서울대학교 치과대학 구강악안면외과학교실) ;
  • 김명진 (서울대학교 치과대학 구강악안면외과학교실)
  • Published : 2002.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common head and neck cancers. OSCC generally has a poor prognosis due to its tendency towards a local invasion and subsequent metastasis, which is mediated by multiple proteolytic enzymes and angiogenesis. Soy products contain high levels of isoflavonoids, including the tyrosine kinase inhibitor, genistein, which has been identified as a potent inhibitor of cell proliferation and in vitro angiogenesis. The purpose of this in vitro study is to evaluate the anti-cancer effect of genistein with respect to the angiogenesis and basement membrane invasion in OSCC. The highly invasive OSCC cell line, HSC-3 cells were cultured in the presence of $10{\mu}M$ genistein for 24h. To evaluate the effects of genistein on the invasiveness and the gelatinolytic activity, in vitro invasion assay and zymography were performed. In order to evaluate the effect on the VEGF and bFGF mRNA expression, RT-PCR and northern hybridization reaction, and chemiluminescence detection were applied. The in vitro invasion assay showed that the genistein treatment reduced the cellular invasion through the artificial basement membrane and significant difference between the control group and the genistein treated group was shown in MMP-2 activity. Especially, the 62 kDa activated form of MMP-2 in the control group was 1.8 times higher than that in the genistein treated group. The results of the northern blot analyses indicated that VEGF mRNA expression in the genistein treated group was significantly down regulated. This study showed that genistein inhibits angiogenesis and reduces basement membrane invasion in OSCC. It seems to support the possibility of genistein as an anti-cancer agent.

Keywords

References

  1. Spiro RH, Alfonso AE, Farr HW, Strong EW: Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg 1974;128: 562-567 https://doi.org/10.1016/0002-9610(74)90276-1
  2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH et al: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887 https://doi.org/10.1093/jnci/84.24.1875
  3. Fox SB: Tumor angiogenesis and prognosis. Histopathol 1997; 30:294-301 https://doi.org/10.1046/j.1365-2559.1997.d01-606.x
  4. Nagase H, Wossner JF Jr: Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494 https://doi.org/10.1074/jbc.274.31.21491
  5. Stetler-Stevenson WG.: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 1999; 103:1237-1241 https://doi.org/10.1172/JCI6870
  6. Thomas GT, Lewis MP, Speight PM: Matrix metalloproteinases and oral cancer. Oral Oncol 1999;35:227-233 https://doi.org/10.1016/S1368-8375(99)00004-4
  7. Folkman J: Introduction: Angiogenesis and cancer. Semin Cancer Biol 1992;3:47-48
  8. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934
  9. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995;13:765-782
  10. Battegay: Angiogenesis: mechanic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995;73:333-346
  11. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI:Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 1994; 111:417-422 https://doi.org/10.1177/019459989411100405
  12. Barinaga M: Designing therapies that target tumor blood vessels. Science. 1997;275:482-484 https://doi.org/10.1126/science.275.5299.482
  13. Coleman KR, Braden GA, Willingham MC, Sane DC: Sane, Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterlemic rabbits. Circ Res 1999;84:1268-1276 https://doi.org/10.1161/01.RES.84.11.1268
  14. Matsumoto K, Ninomiya Y, Inoue M, Tomioka T: Intratumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue. Int J Oral Maxillofac Surg 1999;28:118-124
  15. Ueda N, Kamata N, Hayashi E, Yokoyama K, Hoteiya T, Nagayama M: Effects of an anti-angiogenic agent, TNP- 470, on the growth of oral squamous cell carcinomas. Oral Oncol 1999;35:554-560 https://doi.org/10.1016/S1368-8375(99)00031-7
  16. Giavazzi R, Albini A, Bussolino F, DeBraud F, Presta M, Ziche M et al: The biological basis for antiangiogenic therapy. Eur J Cancer 2000;36:1913-1918 https://doi.org/10.1016/S0959-8049(00)00276-8
  17. Fotsis T, Pepper M S, Montesano R, Aktas E, Breit S, Schweigerer L et al: Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab 1998;12:649-666 https://doi.org/10.1016/S0950-351X(98)80009-8
  18. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L: Genistein, a dietary ingestinal isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995;125:790-797
  19. Cai Q, Wei H: Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 1996;25:1-7 https://doi.org/10.1080/01635589609514423
  20. Zhou Y, Lee AS: Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J Natl Cancer Inst 1998;90:381-388 https://doi.org/10.1093/jnci/90.5.381
  21. Shao ZM, Wu J, Shen ZZ, Barsky SH: Genistein inhibits both constitutive and EGF-stimulated invasion in ERnegative human breast carcinoma cell lines. Anticancer Research 1998;18:1435-1440
  22. Hong SD, Hong SP, Lee JI, Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinoma with regard to the metastatic potential. Oral Oncol 2000;36:207-213 https://doi.org/10.1016/S1368-8375(99)00088-3
  23. Furumatsu T, Nishida K, Kawai A, Namba M, Inoue H, Ninomiya Y: Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Int J Cancer 2002;97:313-322 https://doi.org/10.1002/ijc.1607
  24. Messina MJ, Persky V, Setchell KD, Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-131 https://doi.org/10.1080/01635589409514310